Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia

被引:0
|
作者
Hui He
Jiye Yin
Xi Li
Yu Zhang
Xiaojing Xu
Ming Zhai
Juan Chen
Chenyue Qian
Honghao Zhou
Zhaoqian Liu
机构
[1] Xiangya Hospital,Department of Clinical Pharmacology
[2] Central South University,Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics
[3] Central South University,Department of Hematology
[4] Benxi Central Hospital of China Medical University,Department of Hematology
[5] The First Affiliated Hospital of China Medical University,undefined
关键词
Single nucleotide polymorphism (SNP); Haplotype; Acute myeloid leukemia; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:293 / 302
页数:9
相关论文
共 50 条
  • [41] Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
    Eduardo Megias, Juan
    Montesinos, Pau
    Jose Herrero, Maria
    Moscardo, Federico
    Boso, Virginia
    Martinez-Cuadron, David
    Rojas, Luis
    Rodriguez-Veiga, Rebeca
    Boluda, Blanca
    Martinez, Jesus
    Sanz, Jaime
    Lopez, Francisca
    Cano, Isabel
    Alonso, Carmen
    Lacharro, Aima
    Cervera, Jose
    Luis Poveda, Jose
    Alino, Salvador
    Angel Sanz, Miguel
    BLOOD, 2014, 124 (21)
  • [42] Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia
    Yunis, Luz K.
    Linares-Ballesteros, Adriana
    Aponte, Nelson
    Barros, Gisela
    Garcia, Johnny
    Nino, Laura
    Uribe, Gloria
    Quintero, Edna
    Yunis, Juan J.
    CANCER REPORTS, 2023, 6 (03)
  • [43] PHARMACOGENETICS OF ABCB1, CDA, DCK, GSTT1 AND GSTM1 AND OUTCOMES IN A COHORT OF PEDIATRIC ACUTE MYELOID LEUKEMIA PATIENTS FROM COLOMBIA
    Yunis, Luz
    Linares, Adriana
    Aponte, Nelson
    Barros, Gisela
    Garcia, Johnny
    Nino, Laura
    Uribe, Gloria
    Quintero, Edna
    Yunis, Juan
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S196 - S196
  • [44] Association of ABCB1 polymorphisms with osteonecrosis of the femoral head risk
    Qiao, Guoyong
    Han, Wenhua
    Wang, Dongmei
    Miao, Haimin
    Ma, Zhilin
    Chen, Xinzhi
    Liu, Boyu
    Wang, Shen
    Yin, Junping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 2247 - 2252
  • [45] Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia
    Weich, Natalia
    Ferri, Cristian
    Beatriz Moiraghi, Elena
    Nelida Bengio, Raquel Maria
    Amanda Giere, Isabel
    Pavlovsky, Carolina
    Larripa, Irene
    Freya Fundia, Ariela
    BLOOD, 2015, 126 (23)
  • [46] Association of ABCB1 polymorphisms with lipid homeostasis and liver injury response to atorvastatin in the Chinese population
    Qu, Kan-Kan
    Zhang, Chen-Ning
    Dong, Li-Xia
    Wang, Shu-Shan
    Zhang, Zhong-Dong
    Zhang, Lin
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (01) : 15 - 22
  • [47] Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy
    Meng, Hongmei
    Guo, Guimei
    Ren, Jinyan
    Zhou, Hui
    Ge, Yubin
    Guo, Yingjie
    EPILEPSY & BEHAVIOR, 2011, 21 (01) : 27 - 30
  • [48] Reversing multidrug resistance (MDR1, ABCB1) in acute myeloid leukemia: back to the ABCs
    Rund, Deborah
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2347 - 2348
  • [49] ABCB1 Expression in Acute Myeloid Leukemia (AML): A Possible Predictive Value for Treatment Resistance?
    Correa, Stephany
    Abdelhay, Eliana
    Paschka, Peter
    Gaidzik, Verena I.
    Hassan, Rocio
    Claus, Rainer
    Schlenk, Richard F.
    Doehner, Konstanze
    Bullinger, Lars
    BLOOD, 2014, 124 (21)
  • [50] Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis
    J E Megías-Vericat
    L Rojas
    M J Herrero
    V Bosó
    P Montesinos
    F Moscardó
    J L Poveda
    M A Sanz
    S F Aliño
    The Pharmacogenomics Journal, 2016, 16 : 1 - 2